A citation-based method for searching scientific literature

G Todd Alonso, Laura Pyle, Brigitte Frohnert. Diabetes Res Clin Pract 2017
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
Wendy Lane, Timothy S Bailey, Gregg Gerety, Janusz Gumprecht, Athena Philis-Tsimikas, Charlotte Thim Hansen, Thor S S Nielsen, Mark Warren. JAMA 2017
116
50

Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial.
T Heise, S C Bain, R M Bracken, E Zijlstra, L Nosek, K Stender-Petersen, R Rabøl, E Rowe, H L Haahr. Diabetes Obes Metab 2016
17
50

A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec.
Stefan Korsatko, Sigrid Deller, Gerd Koehler, Julia K Mader, Katharina Neubauer, Charlotte L Adrian, Henrik Thomsen, Hanne Haahr, Thomas R Pieber. Clin Drug Investig 2013
63
50

National standards for diabetes self-management education and support.
Linda Haas, Melinda Maryniuk, Joni Beck, Carla E Cox, Paulina Duker, Laura Edwards, Edwin B Fisher, Lenita Hanson, Daniel Kent, Leslie Kolb,[...]. Diabetes Care 2014
172
50


Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial.
Ryo Iga, Hiroshi Uchino, Ken Kanazawa, Shuki Usui, Masahiko Miyagi, Naoki Kumashiro, Hiroshi Yoshino, Yasuyo Ando, Takahisa Hirose. Diabetes Ther 2017
20
50

Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.
Barbara Bohn, Artur Zimmermann, Christian Wagner, Sigrun Merger, Desirée Dunstheimer, Florian Kopp, Katja Gollisch, Volker Zindel, Reinhard W Holl. Diabetes Res Clin Pract 2017
11
50



Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus.
Michelle L Griffith, Jeffrey B Boord, Svetlana K Eden, Michael E Matheny. J Clin Endocrinol Metab 2012
44
50


Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.
M Monami, N Marchionni, E Mannucci. Diabetes Obes Metab 2009
117
50

Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial.
Roy W Beck, Jean M Lawrence, Lori Laffel, Tim Wysocki, Dongyuan Xing, Elbert S Huang, Brett Ives, Craig Kollman, Joyce Lee, Katrina J Ruedy,[...]. Diabetes Care 2010
73
50

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine.
Tim Heise, Ulrike Hövelmann, Leszek Nosek, Lidia Hermanski, Susanne G Bøttcher, Hanne Haahr. Expert Opin Drug Metab Toxicol 2015
78
50

Concepts and clinical use of ultra-long basal insulin.
Freddy Goldberg Eliaschewitz, Tânia Barreto. Diabetol Metab Syndr 2016
11
50


Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
Chantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, John Cooper, Edward Franek, David Russell-Jones, Jens Larsen, Søren Can Tamer, Stephen C Bain. J Clin Endocrinol Metab 2013
147
50

New approaches to providing individualized diabetes care in the 21st century.
Priscilla W Powell, Sarah D Corathers, Jennifer Raymond, Randi Streisand. Curr Diabetes Rev 2015
30
50

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. J Clin Endocrinol Metab 2013
129
50

Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes.
Torben Biester, Thomas Danne, Sarah Bläsig, Kerstin Remus, Bärbel Aschemeier, Olga Kordonouri, Lars Bardtrum, Hanne Haahr. Pediatr Diabetes 2016
11
50

Lower Basal Insulin Dose is Associated with Better Control in Type 1 Diabetes.
David Strich, Lucy Balagour, Joelle Shenker, David Gillis. J Pediatr 2017
6
50

Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
Tim Heise, Stefan Korsatko, Leszek Nosek, Hans Veit Coester, Sigrid Deller, Carsten Roepstorff, Stine Segel, Rahul Kapur, Hanne Haahr, Marcus Hompesch. J Diabetes 2016
28
50

ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
Thomas Danne, Hans-Jacob Bangstad, Larry Deeb, Przemyslawa Jarosz-Chobot, Lucy Mungaie, Banshi Saboo, Tatsuhiko Urakami, Tadej Battelino, Ragnar Hanas. Pediatr Diabetes 2014
78
50


Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
238
50

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
225
50

Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study.
Julio Rosenstock, Richard M Bergenstal, Thomas C Blevins, Linda A Morrow, Melvin J Prince, Yongming Qu, Vikram P Sinha, Daniel C Howey, Scott J Jacober. Diabetes Care 2013
74
50

Diabetic mastopathy: case report and summary of literature.
Josée Leroux-Stewart, Rémi Rabasa-Lhoret. Can J Diabetes 2014
8
50

Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance.
P Iozzo, H Beck-Nielsen, M Laakso, U Smith, H Yki-Järvinen, E Ferrannini. J Clin Endocrinol Metab 1999
155
50




Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone N Troelsen, Kajsa Kvist, Paul Norwood. JAMA 2017
140
50

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Tim Heise, Leszek Nosek, Birgitte Biilmann Rønn, Lars Endahl, Lutz Heinemann, Christoph Kapitza, Eberhard Draeger. Diabetes 2004
409
50

Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial.
Yukiko Onishi, Yasuhiko Iwamoto, Soon Jib Yoo, Per Clauson, Søren C Tamer, Sungwoo Park. J Diabetes Investig 2013
75
50

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.
Kåre I Birkeland, Philip D Home, Ulrich Wendisch, Robert E Ratner, Thue Johansen, Lars A Endahl, Karsten Lyby, Johan H Jendle, Anthony P Roberts, J Hans DeVries,[...]. Diabetes Care 2011
126
50

Insulin analogues: an example of applied medical science.
B Sheldon, D Russell-Jones, J Wright. Diabetes Obes Metab 2009
42
50

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. Diabetes Technol Ther 2013
154
50


Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes.
Torben Biester, Sarah Blaesig, Kerstin Remus, Bärbel Aschemeier, Olga Kordonouri, Charlotte Granhall, Flemming Søndergaard, Niels Rode Kristensen, Hanne Haahr, Thomas Danne. Pediatr Diabetes 2014
21
50

Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.
Jamie R Wood, Kellee M Miller, David M Maahs, Roy W Beck, Linda A DiMeglio, Ingrid M Libman, Maryanne Quinn, William V Tamborlane, Stephanie E Woerner. Diabetes Care 2013
283
50



Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial.
H W Rodbard, B Cariou, B Zinman, Y Handelsman, A Philis-Tsimikas, T V Skjøth, A Rana, C Mathieu. Diabet Med 2013
64
50



Exercise management in type 1 diabetes: a consensus statement.
Michael C Riddell, Ian W Gallen, Carmel E Smart, Craig E Taplin, Peter Adolfsson, Alistair N Lumb, Aaron Kowalski, Remi Rabasa-Lhoret, Rory J McCrimmon, Carin Hume,[...]. Lancet Diabetes Endocrinol 2017
322
50


Is hypoglycemia fear independently associated with health-related quality of life?
Lizheng Shi, Hui Shao, Yingnan Zhao, Nina A Thomas. Health Qual Life Outcomes 2014
31
50

Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.
Tim Heise, Marianne Nørskov, Leszek Nosek, Kadriye Kaplan, Susanne Famulla, Hanne L Haahr. Diabetes Obes Metab 2017
72
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.